KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Notes Payables (2020)

Ginkgo Bioworks Holdings filings provide 1 years of Notes Payables readings, the most recent being $300000.0 for Q4 2020.

  • On a quarterly basis, Notes Payables changed N/A to $300000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $300000.0, a N/A change, with the full-year FY2020 number at $300000.0, changed N/A from a year prior.
  • Notes Payables hit $300000.0 in Q4 2020 for Ginkgo Bioworks Holdings.
  • In the past five years, Notes Payables ranged from a high of $300000.0 in Q4 2020 to a low of $300000.0 in Q4 2020.